scholarly article | Q13442814 |
P50 | author | Yoshinobu Odaka | Q62016596 |
P2093 | author name string | J Steven Alexander | |
J Michael Mathis | |||
Merilyn H Jennings | |||
Walter Cromer | |||
P2860 | cites work | VEGF stimulation of mitochondrial biogenesis: requirement of AKT3 kinase | Q24318997 |
Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase | Q28646403 | ||
VEGF receptor signalling - in control of vascular function | Q29617256 | ||
ZO-1 stabilizes the tight junction solute barrier through coupling to the perijunctional cytoskeleton | Q30157199 | ||
Angiogenesis in hypertrophic scar of rabbit ears and effect of extracellular protein with metalloprotease and thrombospondin 1 domains on hypertrophic scar | Q33325221 | ||
Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. | Q33899627 | ||
Endothelial cell migration in stable gradients of vascular endothelial growth factor A and fibroblast growth factor 2: effects on chemotaxis and chemokinesis | Q34589498 | ||
Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier | Q36014739 | ||
The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice. | Q36608586 | ||
Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium | Q37350329 | ||
Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line | Q37694752 | ||
VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy. | Q40001026 | ||
Isolation and characterization of a novel mouse lymphatic endothelial cell line: SV-LEC. | Q40367765 | ||
VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression | Q40497297 | ||
VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2. | Q40595312 | ||
Conditionally immortalized cell lines with differentiated functions established from temperature-sensitive T-antigen transgenic mice | Q41117149 | ||
Characterization of the ZO-1 protein in endothelial and other cell lines. | Q41218907 | ||
Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors | Q43213739 | ||
VEGF receptor trafficking in angiogenesis | Q43243512 | ||
VEGF 165 Expressed by a Replication-Deficient Recombinant Adenovirus Vector Induces Angiogenesis In Vivo | Q43580641 | ||
Divergence of angiogenic and vascular permeability signaling by VEGF: inhibition of protein kinase C suppresses VEGF-induced angiogenesis, but promotes VEGF-induced, NO-dependent vascular permeability | Q44030288 | ||
VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma | Q44068637 | ||
The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism | Q45248496 | ||
Induction of focal angiogenesis through adenoviral vector mediated vascular endothelial cell growth factor gene transfer in the mature mouse brain | Q46791545 | ||
The role of vascular endothelial growth factor in a murine chronic granulomatous tissue air pouch model of angiogenesis. | Q53790693 | ||
Angiostatin antagonizes the action of VEGF-A in human endothelial cells via two distinct pathways | Q54749829 | ||
Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: implications for tumor angiogenesis | Q71081146 | ||
The anti-angiogenic VEGF isoform VEGF165b transiently increases hydraulic conductivity, probably through VEGF receptor 1 in vivo | Q82309242 | ||
P433 | issue | 7 | |
P921 | main subject | endothelium | Q111140 |
P304 | page(s) | 536-547 | |
P577 | publication date | 2010-10-01 | |
P1433 | published in | Microcirculation | Q15764357 |
P1476 | title | Murine rVEGF164b, an inhibitory VEGF reduces VEGF-A-dependent endothelial proliferation and barrier dysfunction | |
P478 | volume | 17 |
Q38540137 | Antiangiogenic VEGF-Ax: A New Participant in Tumor Angiogenesis |
Q36232086 | Endothelial Rac1 is essential for hematogenous metastasis to the lung |
Q37195109 | Hydrogen sulfide metabolism regulates endothelial solute barrier function |
Q35965047 | Impairments in the intrinsic contractility of mesenteric collecting lymphatics in a rat model of metabolic syndrome |
Q33959462 | Programmed translational readthrough generates antiangiogenic VEGF-Ax |
Q30619475 | The effects of inflammatory cytokines on lymphatic endothelial barrier function |
Q37359869 | VEGF-A isoform modulation in an preclinical TNBS model of ulcerative colitis: protective effects of a VEGF164b therapy |
Search more.